General Information of Disease (ID: DISO97HC)

Disease Name HIV infectious disease
Synonyms
human immunodeficiency virus infectious disease; Human immunodeficiency virus infectious disease; Human immunodeficiency virus caused disease or disorder; HIV infection; Human immunodeficiency virus disease or disorder
Definition An infection caused by the human immunodeficiency virus.
Disease Hierarchy
DISX17PY: Lentivirus infection
DISV767Z: Viral sexually transmitted disease
DISEM33Q: Infectious disease
DISO97HC: HIV infectious disease
Disease Identifiers
MONDO ID
MONDO_0005109
MESH ID
D015658
UMLS CUI
C0019693
MedGen ID
5583
SNOMED CT ID
86406008

Drug-Interaction Atlas (DIA) of This Disease

Drug-Interaction Atlas (DIA)
This Disease is Treated as An Indication in 1 Approved Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
Tenofovir alafenamide DMTQF4A Approved NA [1]
------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)
This Disease Is Related to 179 DTT Molecule(s)
Gene Name DTT ID Evidence Level Mode of Inheritance REF
APOA1 TT5S8DR Limited Biomarker [2]
BMPR2 TTGKF90 Limited Genetic Variation [3]
CCR3 TTD3XFU Limited Genetic Variation [4]
CXCR1 TTMWT8Z Limited Biomarker [5]
PKN1 TTSL41O Limited Altered Expression [6]
SIRT1 TTUF2HO Limited Biomarker [7]
TOP2B TT4NVEM Limited Altered Expression [8]
ACKR1 TTKY2NS moderate Genetic Variation [9]
ADRB2 TTG8ZWP moderate Biomarker [10]
AGRP TT4DE1O moderate Genetic Variation [11]
APOBEC3G TTP96KH moderate Biomarker [12]
APOL1 TTDB8PW moderate Biomarker [13]
BAX TTQ57WJ moderate Altered Expression [14]
BST2 TT90BJT moderate Biomarker [15]
CCL11 TTCF05Y moderate Biomarker [16]
CCL2 TTNAY0P moderate Biomarker [17]
CCL3 TT8I4WB moderate Biomarker [18]
CCL5 TT9DWLC moderate Biomarker [19]
CD163 TTTZ9DE moderate Biomarker [20]
CD209 TTBXIM9 moderate Genetic Variation [21]
CDKN1A TT9GUW0 moderate Altered Expression [22]
CTSB TTF2LRI moderate Biomarker [23]
CXCL12 TT4UGTF moderate Genetic Variation [24]
DPP4 TTDIGC1 moderate Biomarker [25]
DUSP5 TTZN92A moderate Altered Expression [26]
ENTPD1 TTYM8DJ moderate Altered Expression [27]
FCGR1A TTZK4I3 moderate Altered Expression [28]
FCGR2A TTXT21W moderate Biomarker [29]
GZMB TTKEPHX moderate Biomarker [30]
HLA-G TTLKFB3 moderate Genetic Variation [31]
HSP90AA1 TT78R5H moderate Altered Expression [22]
HSPB1 TT9AZWY moderate Biomarker [32]
ICOS TTE5VP6 moderate Altered Expression [33]
IDO1 TTZJYKH moderate Biomarker [34]
IFNL3 TTRF4Q2 moderate Biomarker [35]
IL2 TTF89GD moderate Biomarker [36]
IL2RA TT10Y9E moderate Biomarker [37]
IL7R TTAWI51 moderate Altered Expression [38]
KIR2DS1 TTVWAGF moderate Biomarker [39]
KIR3DL2 TTQH3N0 moderate Biomarker [39]
MBL2 TTMQDZ5 moderate Biomarker [40]
MDM2 TT9TE0O moderate Genetic Variation [41]
PCSK9 TTNIZ2B moderate Biomarker [42]
PPIB TT6ZFQ4 moderate Biomarker [43]
PSIP1 TTH9LDP moderate Biomarker [44]
SERPINA1 TTA7UJC moderate Biomarker [45]
TACR1 TTZPO1L moderate Biomarker [46]
TLR3 TTD24Y0 moderate Biomarker [47]
TLR9 TTSHG0T moderate Genetic Variation [48]
AADAT TTT3IXG Strong Genetic Variation [49]
ABCB1 TT3OT40 Strong Biomarker [50]
ADRA1D TT34BHT Strong Genetic Variation [51]
ALB TTFNGC9 Strong Altered Expression [52]
APEH TTYWEDQ Strong Biomarker [53]
ATP2A2 TTE6THL Strong Genetic Variation [51]
BIRC2 TTQ5LRD Strong Biomarker [54]
BIRC3 TTAIWZN Strong Biomarker [54]
BRD2 TTDP48B Strong Biomarker [55]
BTLA TTER58P Strong Biomarker [56]
CCL22 TTBTWI1 Strong Genetic Variation [4]
CCR8 TTE836A Strong Genetic Variation [4]
CD160 TTOFEAS Strong Altered Expression [57]
CD1A TTBGTFN Strong Biomarker [58]
CD27 TTDO1MV Strong Biomarker [59]
CD300A TTI2YFK Strong Altered Expression [60]
CD38 TTPURFN Strong Altered Expression [61]
CD3E TTZAT79 Strong Altered Expression [62]
CD3G TTV3XPL Strong Altered Expression [63]
CD4 TTN2JFW Strong Biomarker [64]
CD58 TT5KSBY Strong Biomarker [65]
CD70 TTNCIE0 Strong Biomarker [66]
CDC25B TTR0SWN Strong Altered Expression [67]
CFB TTA0P7K Strong Biomarker [68]
CHRNA7 TTLA931 Strong Altered Expression [69]
CLIC1 TT8KZG6 Strong Biomarker [70]
CR2 TT0HUN7 Strong Genetic Variation [71]
CREB1 TTH4AN3 Strong Biomarker [72]
CRHR2 TTIY658 Strong Altered Expression [73]
CTSA TT5NILS Strong Biomarker [74]
CX3CR1 TT2T98G Strong Genetic Variation [75]
CXCL10 TTQOVYA Strong Biomarker [76]
CXCR5 TTIW59R Strong Altered Expression [77]
CYP2B6 TTMH124 Strong Genetic Variation [78]
DRD3 TT4C8EA Strong Genetic Variation [79]
DRD4 TTE0A2F Strong Genetic Variation [79]
DYRK1A TTSBVFO Strong Biomarker [80]
EIF2AK4 TT9U4EP Strong Biomarker [81]
EIF4EBP1 TTKGEBL Strong Biomarker [70]
ENPEP TT9PBIL Strong Biomarker [82]
ERAP2 TTVGS1C Strong Genetic Variation [83]
FCER2 TTCH6MU Strong Biomarker [84]
FCGR2B TT5RWKQ Strong Biomarker [29]
GEM TTAZF9M Strong Biomarker [39]
GNAO1 TTAXD8Z Strong Genetic Variation [85]
GRB2 TTEYRJ9 Strong Genetic Variation [86]
HBA2 TTQO71U Strong Genetic Variation [87]
HDGF TTKGV26 Strong Biomarker [70]
HEXA TTJI5JW Strong Altered Expression [88]
HEXB TTKIBKM Strong Altered Expression [88]
HIPK2 TTOB49C Strong Biomarker [89]
HLA-DQB2 TTL7VOU Strong Genetic Variation [85]
HP TTLC8E1 Strong Biomarker [90]
HSP90AB1 TTH5YN2 Strong Biomarker [70]
HSPA9 TTMTPG3 Strong Biomarker [70]
HSPD1 TT9HL5R Strong Biomarker [70]
IFNG TT93WF5 Strong Biomarker [91]
IL15 TTJFA35 Strong Biomarker [92]
IL16 TTW4R0B Strong Biomarker [93]
IL17D TTC5LTG Strong Genetic Variation [94]
IL19 TT87RWS Strong Genetic Variation [95]
IL21R TTZO9B0 Strong Biomarker [96]
IL23A TTC1GLB Strong Altered Expression [97]
IL32 TTD4G7L Strong Genetic Variation [98]
ITGAE TTH0Z37 Strong Biomarker [99]
ITGAL TT48WR6 Strong Biomarker [100]
ITK TT3C80U Strong Biomarker [101]
KCNJ3 TTGM19J Strong Biomarker [102]
KIR2DL2 TTU0P73 Strong Biomarker [103]
KIR2DL3 TTEX3SI Strong Biomarker [104]
KLRC1 TTC4IMS Strong Biomarker [105]
KMO TTIY56R Strong Biomarker [106]
KPNB1 TTHOJ5F Strong Biomarker [70]
LAG3 TTNVXAW Strong Biomarker [107]
LAIR1 TTSI7A8 Strong Altered Expression [108]
LAMP1 TTC214J Strong Altered Expression [109]
LANCL1 TTZW8NS Strong Genetic Variation [110]
LCK TT860QF Strong Biomarker [111]
LILRB2 TTHC6XU Strong Altered Expression [112]
LILRB4 TTREOKA Strong Biomarker [15]
LIMK1 TTWL9TY Strong Biomarker [113]
LIPA TTS8T1M Strong Biomarker [114]
LTA4H TTXZEAJ Strong Genetic Variation [115]
LTB4R TTN53ZF Strong Biomarker [116]
LYN TT1RWNJ Strong Biomarker [70]
LYZ TTAOZBW Strong Biomarker [117]
MAP3K11 TTETX6Q Strong Biomarker [118]
MAPKAPK2 TTMUG9D Strong Biomarker [119]
MAZ TT059DA Strong Biomarker [70]
MCOLN1 TT9XBVO Strong Altered Expression [120]
MLYCD TT9Z4YD Strong Biomarker [121]
MMP21 TTYRF5E Strong Genetic Variation [122]
NCL TTK1V5Q Strong Altered Expression [123]
NEDD8 TTNDC4K Strong Biomarker [124]
NLRX1 TTKT026 Strong Biomarker [125]
ODC1 TTUMGNO Strong Biomarker [54]
OGG1 TTRU01G Strong Biomarker [126]
OPRK1 TTQW87Y Strong Genetic Variation [127]
OPRM1 TTKWM86 Strong Genetic Variation [128]
P2RY12 TTZ1DT0 Strong Biomarker [129]
PDCD1 TTNBFWK Strong Altered Expression [130]
PDXP TT9UYG4 Strong Biomarker [131]
PLA2G7 TTDNFMT Strong Altered Expression [132]
PNPLA3 TTEUAEH Strong Genetic Variation [133]
POLB TTA0XPV Strong Altered Expression [134]
PREP TTNGKET Strong Biomarker [135]
PSMB10 TTPNACM Strong Biomarker [70]
RPS6KB1 TTG0U4H Strong Biomarker [119]
RPSA TTLUW5B Strong Genetic Variation [110]
S100B TTQ0V86 Strong Genetic Variation [136]
SDHD TTVH9W8 Strong Biomarker [137]
SELPLG TTS5K8U Strong Biomarker [138]
SIGMAR1 TT5TPI6 Strong Biomarker [139]
SLAMF6 TTSIYJ6 Strong Biomarker [140]
SLAMF7 TT7ILZ1 Strong Biomarker [141]
SLC1A3 TT8WRDA Strong Altered Expression [142]
SPN TTOZAX0 Strong Genetic Variation [143]
STAR TTEI40H Strong Genetic Variation [144]
TACR3 TTBPGLU Strong Altered Expression [145]
TIGIT TTWNL74 Strong Altered Expression [146]
TK1 TTP3QRF Strong Altered Expression [147]
TLR7 TTRJ1K4 Strong Genetic Variation [148]
TLR8 TT8CWFK Strong Genetic Variation [149]
TNFRSF18 TTG6LA7 Strong Altered Expression [150]
TNFSF12 TTBTDM1 Strong Biomarker [151]
TSG101 TTHU7JA Strong Biomarker [152]
TYRP1 TTFRV98 Strong Biomarker [23]
ULK1 TT4D7MJ Strong Altered Expression [153]
VIPR1 TTCL30I Strong Genetic Variation [154]
HLA-B TTGS10J Definitive Genetic Variation [155]
------------------------------------------------------------------------------------
⏷ Show the Full List of 179 DTT(s)
This Disease Is Related to 2 DTP Molecule(s)
Gene Name DTP ID Evidence Level Mode of Inheritance REF
SLC11A1 DT650XW Strong Biomarker [156]
SLC9A6 DTN0JXW Strong Biomarker [157]
------------------------------------------------------------------------------------
This Disease Is Related to 4 DME Molecule(s)
Gene Name DME ID Evidence Level Mode of Inheritance REF
GPT DER5HFI moderate Biomarker [158]
DTYMK DEOTVYU Strong Altered Expression [147]
NDUFS7 DEIW03B Strong Genetic Variation [159]
PON3 DETXQZ1 Strong Biomarker [160]
------------------------------------------------------------------------------------
This Disease Is Related to 219 DOT Molecule(s)
Gene Name DOT ID Evidence Level Mode of Inheritance REF
NRGN OTVGE10W Limited Biomarker [161]
TMSB15A OTSBWCES Disputed Biomarker [162]
ARTN OTWIWGL6 moderate Genetic Variation [11]
B3GAT1 OTXFP98E moderate Altered Expression [163]
CLEC4M OT2WUIIP moderate Biomarker [164]
CTNND2 OTYKE30Y moderate Genetic Variation [165]
DOCK2 OTZTS3PA moderate Biomarker [166]
FUT1 OTODG57A moderate Biomarker [167]
HLA-E OTX1CTFB moderate Biomarker [105]
IL27 OTIS3OF8 moderate Genetic Variation [94]
ILF2 OTWWVM9X moderate Biomarker [168]
IPO7 OTDFMQ00 moderate Biomarker [169]
ITIH4 OT460OO1 moderate Genetic Variation [170]
LGALS9 OT7MF91K moderate Biomarker [171]
MACROD2 OTNQCHC6 moderate Genetic Variation [165]
MIP OTEBLU3E moderate Biomarker [154]
MYDGF OT9HRPL6 moderate Genetic Variation [94]
PSMD7 OT7PZZ4K moderate Genetic Variation [110]
RNF2 OTFPLOIN moderate Altered Expression [172]
SCD5 OTSSUQ3Z moderate Altered Expression [173]
TRIM22 OTJBLG5R moderate Biomarker [174]
AADAC OT8VACT2 Strong Biomarker [175]
ACOT8 OTHY684G Strong Biomarker [176]
ADAM11 OTPTVW5W Strong Altered Expression [177]
ADI1 OT8IOD03 Strong Genetic Variation [178]
ADRM1 OTOU4EY6 Strong Biomarker [179]
ALYREF OTOF2ADD Strong Biomarker [70]
APOBEC3F OT750IJM Strong Biomarker [180]
ARAP3 OTUWZTH7 Strong Biomarker [70]
ARHGAP4 OTXV053R Strong Biomarker [70]
ARHGDIA OTEXWJDO Strong Biomarker [70]
ARHGDIB OT9PD6CS Strong Biomarker [70]
ARHGEF2 OTBQTFRT Strong Genetic Variation [110]
ARIH2 OTJYJQJ8 Strong Biomarker [12]
ARMH1 OTTJC0D6 Strong Genetic Variation [110]
ARSH OTG0X9UQ Strong Genetic Variation [86]
ATG12 OTJRO09Y Strong Altered Expression [153]
BAG3 OTVXYUDQ Strong Biomarker [181]
BATF OT9VSD2D Strong Altered Expression [182]
BCL11B OT8KKCVJ Strong Biomarker [183]
BCS1L OT5PY5CY Strong Biomarker [184]
BTBD8 OT3A3RD7 Strong Genetic Variation [185]
CACNA2D4 OTVYNX7N Strong Biomarker [186]
CBFA2T2 OTNOIB23 Strong Biomarker [187]
CCL19 OTQ2UJMH Strong Biomarker [188]
CCL28 OTY6XNQ7 Strong Genetic Variation [189]
CCL4 OT6B8P25 Strong Biomarker [190]
CCL4L2 OTDBSXOU Strong Biomarker [18]
CCNT1 OTDYVGCP Strong Altered Expression [191]
CCT3 OTL6EOS1 Strong Biomarker [70]
CCT5 OTPZ38BT Strong Biomarker [70]
CCT7 OTQNM3CY Strong Biomarker [70]
CD1C OT4XINUJ Strong Biomarker [192]
CD207 OTI9RUDN Strong Biomarker [193]
CD244 OTSMR85N Strong Genetic Variation [194]
CD247 OT45FGUX Strong Biomarker [195]
CDC42 OT5QBC5M Strong Biomarker [6]
CEBPZ OT11BATG Strong Biomarker [196]
CLEC10A OTD8HQT6 Strong Biomarker [197]
CLEC4E OT7P8ICY Strong Genetic Variation [198]
CMIP OTZN8Z4A Strong Altered Expression [199]
COLEC11 OT4GC46Y Strong Biomarker [200]
COMMD1 OT7WUD5R Strong Biomarker [201]
COPS6 OTG9AAG0 Strong Biomarker [70]
CUL5 OTMTZD47 Strong Biomarker [12]
DCLRE1B OT2LFW7A Strong Biomarker [202]
DEFA5 OT95CBQ9 Strong Biomarker [203]
DEGS2 OTXC27FL Strong Biomarker [204]
DNAJC7 OTQ5AL3F Strong Biomarker [70]
DRAM1 OTIJTXEN Strong Altered Expression [205]
DTX1 OTYX91DX Strong Biomarker [206]
EBNA1BP2 OTBRVMZH Strong Genetic Variation [110]
EDN3 OTN7Q9BE Strong Biomarker [204]
EIF3B OTF67VPH Strong Biomarker [70]
EIF3D OTDOMP80 Strong Biomarker [207]
EIF4A1 OTMTBX6N Strong Biomarker [70]
EIF6 OTEXMUED Strong Biomarker [70]
ELK4 OTVSSEOE Strong Biomarker [208]
EMB OT67E3Q1 Strong Biomarker [209]
EMG1 OTFDX7HY Strong Biomarker [70]
ERVW-1 OTWV8DXJ Strong Biomarker [210]
FAM72A OTBZYSR3 Strong Biomarker [5]
FAM72B OT6AOG64 Strong Biomarker [5]
FBL OTRODIE5 Strong Biomarker [211]
FCGR2C OTNLMNYB Strong Biomarker [29]
FLT3LG OTU0YGC4 Strong Biomarker [212]
FREM1 OTMHRV87 Strong Genetic Variation [213]
FUCA1 OTW71IK4 Strong Altered Expression [88]
FUT2 OTLXM6WI Strong Genetic Variation [214]
GADD45A OTDRV63V Strong Biomarker [54]
GALT OTCATU66 Strong Biomarker [215]
GOLGB1 OT2S0GK8 Strong Biomarker [216]
GPR15 OTK8674M Strong Biomarker [217]
GRPEL1 OT8O00YJ Strong Biomarker [70]
GTF3A OTVROUVQ Strong Biomarker [70]
HADHA OTO557N2 Strong Biomarker [204]
HAVCR2 OTOL603T Strong Altered Expression [218]
HBA1 OTW2BQF4 Strong Genetic Variation [87]
HCP5 OTV0YRI8 Strong Genetic Variation [219]
HLA-F OT76CM19 Strong Altered Expression [220]
HSPBP1 OTRS37HK Strong Biomarker [221]
HSPH1 OTVRR73T Strong Biomarker [70]
ICAM2 OT3E070F Strong Biomarker [222]
ICAM3 OTTZ5A5D Strong Biomarker [223]
IFI16 OT4SPU0U Strong Biomarker [224]
IFI44 OTOKSZVA Strong Biomarker [225]
IFITM3 OT2QP8D3 Strong Genetic Variation [226]
IFNA17 OTHXRYG3 Strong Altered Expression [227]
IL18BP OTW0LRYZ Strong Altered Expression [228]
IL2RG OTRZ3OMY Strong Biomarker [229]
ILF3 OTKMZ5K5 Strong Biomarker [168]
INSRR OT3F75WA Strong Biomarker [230]
IRF7 OTC1A2PQ Strong Biomarker [187]
ITPA OTQ47WVR Strong Genetic Variation [231]
KIR3DS1 OTJWIO4T Strong Altered Expression [220]
KLRB1 OTQ2959Y Strong Altered Expression [232]
KLRC2 OTT4N86S Strong Genetic Variation [233]
KLRD1 OTMYLOV4 Strong Genetic Variation [234]
KMT2E OTYOLNOG Strong Biomarker [235]
LEAP2 OTUOPIS5 Strong Altered Expression [236]
LILRA2 OT1O2K47 Strong Biomarker [15]
LILRA3 OTBNQCOS Strong Genetic Variation [237]
LRRCC1 OTVEBJ1V Strong Biomarker [208]
MAN1A1 OT6LIGJP Strong Altered Expression [88]
MATR3 OTESJ5S7 Strong Altered Expression [238]
MKKS OTLF5T11 Strong Biomarker [239]
MKS1 OT83W5PB Strong Biomarker [239]
MMP23B OT2OR6TS Strong Genetic Variation [122]
MUC5B OTPW6K5C Strong Altered Expression [240]
NCOR2 OTY917X0 Strong Genetic Variation [241]
NCR2 OT2H13BX Strong Biomarker [242]
NCR3 OT20M764 Strong Altered Expression [243]
NDE1 OT2N8Q17 Strong Biomarker [244]
NDUFA6 OTEOIIOL Strong Altered Expression [245]
NEBL OT2WH1NC Strong Genetic Variation [246]
NEIL1 OTHBU5DJ Strong Biomarker [247]
NUP88 OT647WOR Strong Biomarker [70]
NUTF2 OT8VA2ZF Strong Biomarker [70]
OR10A4 OTYYB8SY Strong Biomarker [248]
PANX1 OTXPEDOK Strong Biomarker [249]
PAPPA OTTTG9PG Strong Biomarker [250]
PDLIM7 OTAZVODU Strong Biomarker [251]
PDYN OTEJ6430 Strong Genetic Variation [127]
PI3 OT47MTC3 Strong Altered Expression [252]
PIK3R2 OTZSUQK5 Strong Biomarker [187]
PMAIP1 OTXEE550 Strong Genetic Variation [253]
POLE3 OTOELRF6 Strong Biomarker [5]
PPP1R12C OT9Q86JO Strong Biomarker [187]
PPP1R13B OTC88VQO Strong Biomarker [187]
PRF1 OTFVXD7H Strong Biomarker [254]
PRMT6 OT5V3XIN Strong Altered Expression [255]
PRPF8 OTU39JZI Strong Biomarker [70]
PRSS21 OT8ZYC7G Strong Biomarker [256]
PSAP OTUOEKY7 Strong Biomarker [208]
PSMA4 OTAD2XXI Strong Biomarker [70]
PSMA5 OT38E6Y1 Strong Biomarker [70]
PSMA6 OTJ6RPX5 Strong Biomarker [70]
PSMB4 OTOJ9OHA Strong Biomarker [70]
PSMC3 OTSKT0JI Strong Biomarker [70]
PSMC5 OTJOORMR Strong Biomarker [70]
PSMD13 OTNQ351N Strong Biomarker [70]
PSMD3 OT585WY8 Strong Biomarker [70]
PSMD6 OTX59EGK Strong Biomarker [70]
PSMD8 OTY6X27P Strong Biomarker [70]
PSME1 OTDHLJWH Strong Biomarker [70]
PSME2 OTYPP33T Strong Biomarker [70]
PSME3 OTSTC4YY Strong Biomarker [70]
PSME4 OTDGF53O Strong Biomarker [70]
PTBP2 OTF4S7NE Strong Genetic Variation [257]
PTCH1 OTMG07H5 Strong Biomarker [54]
PTPN22 OTDCNTC3 Strong Biomarker [135]
PTPN4 OT6SXU5Y Strong Biomarker [258]
PTPRH OTDUHQGF Strong Biomarker [208]
PVALB OTZW1WVQ Strong Altered Expression [259]
RAB11B OT6GI23M Strong Biomarker [70]
RAB32 OTTR4H7S Strong Biomarker [70]
RAB4A OT7BL9WW Strong Genetic Variation [260]
RABEPK OTCZSREH Strong Genetic Variation [110]
RAG2 OTG9UYTW Strong Biomarker [116]
RAN OT2TER5M Strong Biomarker [70]
RANBP1 OTQE226K Strong Biomarker [70]
RAPGEF5 OT53VS75 Strong Biomarker [261]
RBBP4 OTG3BT3M Strong Biomarker [262]
RBM8A OT5SR6G0 Strong Biomarker [263]
RCAN1 OT1MVXC7 Strong Altered Expression [264]
RNF39 OTUQA9JT Strong Genetic Variation [265]
RNH1 OT6EC79B Strong Biomarker [266]
RPL17 OTTYMPS6 Strong Biomarker [267]
RYR3 OT4EHIP4 Strong Genetic Variation [268]
SAMHD1 OTBCIBC7 Strong Genetic Variation [269]
SAMM50 OTRYFYIU Strong Genetic Variation [270]
SCLT1 OT2ZSSP4 Strong Biomarker [208]
SEM1 OTASLBM1 Strong Biomarker [271]
SEMA4A OT8901H3 Strong Altered Expression [272]
SERPINA7 OTUYVTSU Strong Biomarker [273]
SF3A3 OTHBGNXE Strong Biomarker [70]
SFPQ OTLCIAPJ Strong Biomarker [70]
SIGIRR OTNC3XFD Strong Altered Expression [274]
SLAMF1 OTBTT3ZQ Strong Altered Expression [275]
SLFN11 OTJWFPMY Strong Biomarker [276]
SNRPD3 OTZXBQ45 Strong Biomarker [70]
SPATA2 OTOA45GL Strong Biomarker [267]
SRF OTW18FQN Strong Biomarker [70]
SRSF1 OTF61HOV Strong Biomarker [70]
SRSF9 OT2STDP4 Strong Biomarker [70]
SRY OT516T6D Strong Biomarker [277]
STING1 OTDAP4G0 Strong Biomarker [278]
SUN2 OT2IQJUC Strong Biomarker [279]
TAF8 OTWWGCHV Strong Biomarker [280]
TAF9 OTCTH3C6 Strong Biomarker [70]
TAT OT2CJ91O Strong Altered Expression [281]
TBATA OTGDMAAL Strong Genetic Variation [282]
TMED1 OTWSH0J8 Strong Altered Expression [283]
TNFSF9 OTV9L89D Strong Altered Expression [284]
TNPO3 OTOT3HH0 Strong Biomarker [285]
TRAF1 OTTLM5RU Strong Biomarker [286]
TREX1 OTQG7K12 Strong Genetic Variation [287]
TRIM5 OTMZH7EJ Strong Biomarker [288]
TSC22D1 OTN4GFWD Strong Biomarker [289]
------------------------------------------------------------------------------------
⏷ Show the Full List of 219 DOT(s)

References

1 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
2 Anti-apolipoprotein A-1 autoantibodies are associated with immunodeficiency and systemic inflammation in HIV patients.J Infect. 2018 Feb;76(2):186-195. doi: 10.1016/j.jinf.2017.11.008. Epub 2017 Dec 14.
3 Primary pulmonary hypertension after amfepramone (diethylpropion) with BMPR2 mutation.Eur Respir J. 2003 Sep;22(3):560-2. doi: 10.1183/09031936.03.00095303.
4 Novel genetic associations and gene-gene interactions of chemokine receptor and chemokine genetic polymorphisms in HIV/AIDS.AIDS. 2017 Jun 1;31(9):1235-1243. doi: 10.1097/QAD.0000000000001491.
5 A CXCR1 haplotype hampers HIV-1 matrix protein p17 biological activity.AIDS. 2014 Oct 23;28(16):2355-64. doi: 10.1097/QAD.0000000000000423.
6 Cdc42 and RhoB activation are required for mannose receptor-mediated phagocytosis by human alveolar macrophages.Mol Biol Cell. 2005 Feb;16(2):824-34. doi: 10.1091/mbc.e04-06-0463. Epub 2004 Dec 1.
7 Use of the Monte Carlo Method for OECD Principles-Guided QSAR Modeling of SIRT1 Inhibitors.Arch Pharm (Weinheim). 2017 Jan;350(1). doi: 10.1002/ardp.201600268. Epub 2016 Dec 26.
8 Topoisomerase II and its role in different biological contexts.Arch Biochem Biophys. 2017 Nov 1;633:78-84. doi: 10.1016/j.abb.2017.06.021. Epub 2017 Jun 29.
9 The Duffy antigen receptor for chemokines, ACKR1,- 'Jeanne DARC' of benign neutropenia.Br J Haematol. 2019 Feb;184(4):497-507. doi: 10.1111/bjh.15730. Epub 2018 Dec 27.
10 -Adrenergic receptor gene expression in HIV-associated neurocognitive impairment and encephalitis: implications for MOR-1K subcellular localization.J Neurovirol. 2016 Dec;22(6):866-870. doi: 10.1007/s13365-016-0464-1. Epub 2016 Jul 11.
11 Impact of NRTI resistance mutations on virological effectiveness of antiretroviral regimens containing elvitegravir: a multi-cohort study.J Antimicrob Chemother. 2020 Jan 1;75(1):194-199. doi: 10.1093/jac/dkz424.
12 ARIH2 Is a Vif-Dependent Regulator of CUL5-Mediated APOBEC3G Degradation in HIV Infection.Cell Host Microbe. 2019 Jul 10;26(1):86-99.e7. doi: 10.1016/j.chom.2019.05.008. Epub 2019 Jun 25.
13 APOL1-Associated Collapsing Focal Segmental Glomerulosclerosis in a Patient With Stimulator of Interferon Genes (STING)-Associated Vasculopathy With Onset in Infancy (SAVI).Am J Kidney Dis. 2020 Feb;75(2):287-290. doi: 10.1053/j.ajkd.2019.07.010. Epub 2019 Oct 7.
14 TREM-1 Protects HIV-1-Infected Macrophages from Apoptosis through Maintenance of Mitochondrial Function.mBio. 2019 Nov 12;10(6):e02638-19. doi: 10.1128/mBio.02638-19.
15 Mass Cytometry Analysis Reveals Complex Cell-State Modifications of Blood Myeloid Cells During HIV Infection.Front Immunol. 2019 Nov 22;10:2677. doi: 10.3389/fimmu.2019.02677. eCollection 2019.
16 Low-Dose Maraviroc, an Antiretroviral Drug, Attenuates the Infiltration of T Cells into the Central Nervous System and Protects the Nigrostriatum in Hemiparkinsonian Monkeys.J Immunol. 2019 Jun 15;202(12):3412-3422. doi: 10.4049/jimmunol.1800587.
17 Short Communication: A Quantitative System for Monitoring Blood-Circulating Viral Protein R of Human Immunodeficiency Virus-1 Detected a Possible Link with Pathogenic Indices.AIDS Res Hum Retroviruses. 2019 Jul;35(7):660-663. doi: 10.1089/AID.2019.0016. Epub 2019 May 6.
18 Genital inflammation and the risk of HIV acquisition in women.Clin Infect Dis. 2015 Jul 15;61(2):260-9. doi: 10.1093/cid/civ298. Epub 2015 Apr 21.
19 Effects of Tobacco Usage and Antiretroviral Therapy on Biomarkers of Systemic Immune Activation in HIV-Infected Participants.Mediators Inflamm. 2018 Dec 9;2018:8357109. doi: 10.1155/2018/8357109. eCollection 2018.
20 Soluble CD163 predicts incident chronic lung, kidney and liver disease in HIV infection.AIDS. 2017 Apr 24;31(7):981-988. doi: 10.1097/QAD.0000000000001432.
21 CD4 intragenic SNPs associate with HIV-2 plasma viral load and CD4 count in a community-based study from Guinea-Bissau, West Africa.J Acquir Immune Defic Syndr. 2011 Jan 1;56(1):1-8. doi: 10.1097/QAI.0b013e3181f638ed.
22 Alteration of select gene expression patterns in individuals infected with HIV-1.J Med Virol. 2014 Apr;86(4):678-86. doi: 10.1002/jmv.23872. Epub 2014 Jan 30.
23 HIV Infection Induces Extracellular Cathepsin B Uptake and Damage to Neurons.Sci Rep. 2019 May 29;9(1):8006. doi: 10.1038/s41598-019-44463-1.
24 Genetic variation in CCR2 and CXCL12 genes impacts on CD4 restoration in patients initiating cART with advanced immunesupression.PLoS One. 2019 Mar 28;14(3):e0214421. doi: 10.1371/journal.pone.0214421. eCollection 2019.
25 A Randomized, Double-blinded, Placebo-controlled Trial of Sitagliptin for Reducing Inflammation and Immune Activation in Treated and Suppressed Human Immunodeficiency Virus Infection.Clin Infect Dis. 2019 Sep 13;69(7):1165-1172. doi: 10.1093/cid/ciy1051.
26 VH3 gene expression in children with HIV infection.J Infect. 2004 Nov;49(4):274-82. doi: 10.1016/j.jinf.2004.04.007.
27 Expression of CD39 Is Correlated With HIV DNA Levels in Nave Tregs in Chronically Infected ART Nave Patients.Front Immunol. 2019 Oct 17;10:2465. doi: 10.3389/fimmu.2019.02465. eCollection 2019.
28 The Expression Level of Neutrophil CD64 Is a Useful Marker of Systemic Inflammation Associated with HIV Infection.AIDS Res Hum Retroviruses. 2017 Feb;33(2):147-156. doi: 10.1089/AID.2016.0107. Epub 2016 Oct 27.
29 CD32 is expressed on cells with transcriptionally active HIV but does not enrich for HIV DNA in resting T cells.Sci Transl Med. 2018 Apr 18;10(437):eaar6759. doi: 10.1126/scitranslmed.aar6759.
30 HIV-Specific Granzyme B-Secreting but Not Gamma Interferon-Secreting T Cells Are Associated with Reduced Viral Reservoirs in Early HIV Infection.J Virol. 2017 Mar 29;91(8):e02233-16. doi: 10.1128/JVI.02233-16. Print 2017 Apr 15.
31 Variation sites at the HLA-G 3' untranslated region confer differential susceptibility to HIV/HPV co-infection and aneuploidy in cervical cell.PLoS One. 2018 Oct 2;13(10):e0204679. doi: 10.1371/journal.pone.0204679. eCollection 2018.
32 Anti-vpr activities of heat shock protein 27.Mol Med. 2007 May-Jun;13(5-6):229-39. doi: 10.2119/2007?0004.Liang.
33 Mapping the Lineage Relationship between CXCR5(+) and CXCR5(-) CD4(+) T Cells in HIV-Infected Human Lymph Nodes.Cell Rep. 2019 Sep 17;28(12):3047-3060.e7. doi: 10.1016/j.celrep.2019.08.037.
34 Increased Tryptophan Catabolism Is Associated With Increased Frequency of CD161+Tc17/MAIT Cells and Lower CD4+ T-Cell Count in HIV-1 Infected Patients on cART After 2 Years of Follow-Up.J Acquir Immune Defic Syndr. 2015 Nov 1;70(3):228-35. doi: 10.1097/QAI.0000000000000758.
35 IFN-4 inhibits HIV infection of macrophages through signalling of IFN-R1/IL-10R2 receptor complex.Scand J Immunol. 2018 Nov;88(5):e12717. doi: 10.1111/sji.12717. Epub 2018 Oct 10.
36 Immune signatures for HIV-1 and HIV-2 induced CD4(+)T cell dysregulation in an Indian cohort.BMC Infect Dis. 2019 Feb 11;19(1):135. doi: 10.1186/s12879-019-3743-7.
37 CD25+ FoxP3+ Memory CD4 T Cells Are Frequent Targets of HIV Infection In Vivo.J Virol. 2016 Sep 29;90(20):8954-67. doi: 10.1128/JVI.00612-16. Print 2016 Oct 15.
38 IL-7-induced proliferation of peripheral Th17 cells is impaired in HAART-controlled HIV infection.AIDS. 2019 May 1;33(6):985-991. doi: 10.1097/QAD.0000000000002164.
39 KIR and HLA-C Genetic Polymorphisms Influence Plasma IP-10 Concentration in Antiretroviral Therapy-Naive HIV-Infected Adult Zimbabweans.OMICS. 2019 Feb;23(2):111-118. doi: 10.1089/omi.2018.0147. Epub 2019 Jan 7.
40 A dual role for Mannan-binding lectin-associated serine protease 2 (MASP-2) in HIV infection.Mol Immunol. 2016 Oct;78:48-56. doi: 10.1016/j.molimm.2016.08.015. Epub 2016 Aug 30.
41 Evidence for an epistatic effect between TP53 R72P and MDM2 T309G SNPs in HIV infection: a cross-sectional study in women from South Brazil.PLoS One. 2014 Feb 28;9(2):e89489. doi: 10.1371/journal.pone.0089489. eCollection 2014.
42 Pro-protein subtilisin kexin-9 (PCSK9) inhibition in practice: lipid clinic experience in 2 contrasting UK centres.Int J Clin Pract. 2017 Nov;71(11). doi: 10.1111/ijcp.13032. Epub 2017 Oct 10.
43 Cyclophilin B enhances HIV-1 infection.Virology. 2016 Feb;489:282-91. doi: 10.1016/j.virol.2015.12.015. Epub 2016 Jan 14.
44 Targeted editing of the PSIP1 gene encoding LEDGF/p75 protects cells against HIV infection.Sci Rep. 2019 Feb 20;9(1):2389. doi: 10.1038/s41598-019-38718-0.
45 HIV infection is independently associated with a higher concentration of alpha-1 antitrypsin.HIV Med. 2018 Nov;19(10):745-750. doi: 10.1111/hiv.12666. Epub 2018 Aug 30.
46 Substance P-mediated chemokine production promotes monocyte migration.J Leukoc Biol. 2017 Apr;101(4):967-973. doi: 10.1189/jlb.1AB0416-188RR. Epub 2016 Oct 21.
47 CCR2 Signaling Selectively Regulates IFN-: Role of -Arrestin 2 in IFNAR1 Internalization.J Immunol. 2019 Jan 1;202(1):105-118. doi: 10.4049/jimmunol.1800598. Epub 2018 Nov 30.
48 TLR9 polymorphism correlates with immune activation, CD4 decline and plasma IP10 levels in HIV patients.BMC Infect Dis. 2019 Jan 16;19(1):56. doi: 10.1186/s12879-019-3697-9.
49 Polymorphism of Kynurenine Pathway-Related Genes, Kynurenic Acid, and Psychopathological Symptoms in HIV.J Neuroimmune Pharmacol. 2016 Sep;11(3):549-61. doi: 10.1007/s11481-016-9668-7. Epub 2016 Apr 12.
50 Expression of ATP-binding cassette membrane transporters in a HIV-1 transgenic rat model.Biochem Biophys Res Commun. 2014 Feb 21;444(4):531-6. doi: 10.1016/j.bbrc.2014.01.092. Epub 2014 Jan 25.
51 Altruism, Scepticism, and collective decision-making in foreign-born U.S. residents in a tuberculosis vaccine trial.BMC Public Health. 2018 Apr 23;18(1):535. doi: 10.1186/s12889-018-5460-3.
52 Serum albumin and mortality in patients with HIV and end-stage renal failure on peritoneal dialysis.PLoS One. 2019 Jun 10;14(6):e0218156. doi: 10.1371/journal.pone.0218156. eCollection 2019.
53 The anti-caspase inhibitor Q-VD-OPH prevents AIDS disease progression in SIV-infected rhesus macaques.J Clin Invest. 2018 Apr 2;128(4):1627-1640. doi: 10.1172/JCI95127. Epub 2018 Mar 19.
54 Anti-HIV activity of olive leaf extract (OLE) and modulation of host cell gene expression by HIV-1 infection and OLE treatment.Biochem Biophys Res Commun. 2003 Aug 8;307(4):1029-37. doi: 10.1016/s0006-291x(03)01292-0.
55 In the NAT era, is routine lookback to recipients still required when donors seroconvert for HIV infection?.Vox Sang. 2019 May;114(4):394-396. doi: 10.1111/vox.12767. Epub 2019 Feb 28.
56 HIV Infection Is Associated With Downregulation of BTLA Expression on Mycobacterium tuberculosis-Specific CD4 T Cells in Active Tuberculosis Disease.Front Immunol. 2019 Aug 21;10:1983. doi: 10.3389/fimmu.2019.01983. eCollection 2019.
57 Early and Delayed Antiretroviral Therapy Results in Comparable Reductions in CD8(+) T Cell Exhaustion Marker Expression.AIDS Res Hum Retroviruses. 2017 Jul;33(7):658-667. doi: 10.1089/AID.2016.0324. Epub 2017 Apr 25.
58 A case of symptomatic primary HIV infection.J Dermatol. 2005 Feb;32(2):137-42. doi: 10.1111/j.1346-8138.2005.tb00732.x.
59 Clonal expansion and functional exhaustion of monoclonal marginal zone B cells in mixed cryoglobulinemia: the yin and yang of HCV-driven lymphoproliferation and autoimmunity.Autoimmun Rev. 2013 Jan;12(3):430-5. doi: 10.1016/j.autrev.2012.08.016. Epub 2012 Aug 23.
60 Altered Expression of CD300a Inhibitory Receptor on CD4+ T Cells From Human Immunodeficiency Virus-1-Infected Patients: Association With Disease Progression Markers.Front Immunol. 2018 Jul 23;9:1709. doi: 10.3389/fimmu.2018.01709. eCollection 2018.
61 Effect of Withania somnifer on CD38 expression on CD8+ T lymphocytes among patients of HIV infection.Clin Immunol. 2019 Jun;203:122-124. doi: 10.1016/j.clim.2019.04.003. Epub 2019 Apr 17.
62 CD3 Expression Defines Functionally Distinct Subsets of V1 T Cells in Patients With Human Immunodeficiency Virus Infection.Front Immunol. 2018 May 2;9:940. doi: 10.3389/fimmu.2018.00940. eCollection 2018.
63 A specific defect in CD3 gamma-chain gene transcription results in loss of T-cell receptor/CD3 expression late after human immunodeficiency virus infection of a CD4+ T-cell line.Proc Natl Acad Sci U S A. 1990 Sep;87(17):6713-7. doi: 10.1073/pnas.87.17.6713.
64 Native X-DING-CD4 protein secreted by HIV-1 resistant CD4+ T cells blocks activity of IL-8 promoter in human endothelial cells infected with enteric bacteria.Innate Immun. 2012 Aug;18(4):571-579. doi: 10.1177/1753425911427065. Epub 2011 Oct 26.
65 Lack of T-cell-mediated IL-2 and TNF production is linked to decreased CD58 expression in intestinal tissue during acute simian immunodeficiency virus infection.J Gen Virol. 2019 Jan;100(1):26-34. doi: 10.1099/jgv.0.001181. Epub 2018 Nov 29.
66 Immune Checkpoints as the Immune System Regulators and Potential Biomarkers in HIV-1 Infection.Int J Mol Sci. 2018 Jul 9;19(7):2000. doi: 10.3390/ijms19072000.
67 HIV and Cocaine Impact Glial Metabolism: Energy Sensor AMP-activated protein kinase Role in Mitochondrial Biogenesis and Epigenetic Remodeling.Sci Rep. 2016 Aug 18;6:31784. doi: 10.1038/srep31784.
68 Bf S gene frequency in Nigerians with HIV infection.Dis Markers. 1991 Nov-Dec;9(6):333-8.
69 Expression of CHRFAM7A and CHRNA7 in neuronal cells and postmortem brain of HIV-infected patients: considerations for HIV-associated neurocognitive disorder.J Neurovirol. 2016 Jun;22(3):327-35. doi: 10.1007/s13365-015-0401-8. Epub 2015 Nov 13.
70 Host cell gene expression during human immunodeficiency virus type 1 latency and reactivation and effects of targeting genes that are differentially expressed in viral latency.J Virol. 2004 Sep;78(17):9458-73. doi: 10.1128/JVI.78.17.9458-9473.2004.
71 Association of complement C3d receptor 2 genotypes with the acquisition of HIV infection in a trial of recombinant glycoprotein 120 vaccine.AIDS. 2020 Jan 1;34(1):25-32. doi: 10.1097/QAD.0000000000002401.
72 Experienced discrimination and racial differences in leukocyte gene expression.Psychoneuroendocrinology. 2019 Aug;106:277-283. doi: 10.1016/j.psyneuen.2019.04.016. Epub 2019 Apr 19.
73 Corticotropin-releasing factor receptor subtype 2 in human colonic mucosa: down-regulation in ulcerative colitis.World J Gastroenterol. 2013 Mar 7;19(9):1416-23. doi: 10.3748/wjg.v19.i9.1416.
74 Mechanistic Studies of Viral Entry: An Overview of Dendrimer-Based Microbicides As Entry Inhibitors Against Both HIV and HSV-2 Overlapped Infections.Med Res Rev. 2017 Jan;37(1):149-179. doi: 10.1002/med.21405. Epub 2016 Aug 12.
75 CCR2, CX3CR1, RANTES and SDF1 genetic polymorphisms influence HIV infection in a Zimbabwean pediatric population.J Infect Dev Ctries. 2014 Oct 15;8(10):1313-21. doi: 10.3855/jidc.4599.
76 IP-10 is highly involved in HIV infection.Cytokine. 2019 Mar;115:97-103. doi: 10.1016/j.cyto.2018.11.018. Epub 2018 Nov 22.
77 Does B Cell Follicle Exclusion of CD8+ T Cells Make Lymph Nodes Sanctuaries of HIV Replication?.Front Immunol. 2019 Oct 9;10:2362. doi: 10.3389/fimmu.2019.02362. eCollection 2019.
78 CYP2B6 genotype-directed dosing is required for optimal efavirenz exposure in children 3-36 months with HIV infection.AIDS. 2017 May 15;31(8):1129-1136. doi: 10.1097/QAD.0000000000001463.
79 The dopamine-related polymorphisms BDNF, COMT, DRD2, DRD3, and DRD4 are not linked with changes in CSF dopamine levels and frequency of HIV infection.J Neural Transm (Vienna). 2017 Apr;124(4):501-509. doi: 10.1007/s00702-016-1659-6. Epub 2016 Dec 1.
80 HIV-1-Tat Protein Inhibits SC35-mediated Tau Exon 10 Inclusion through Up-regulation of DYRK1A Kinase.J Biol Chem. 2015 Dec 25;290(52):30931-46. doi: 10.1074/jbc.M115.675751. Epub 2015 Nov 3.
81 HIV Exploits Antiviral Host Innate GCN2-ATF4 Signaling for Establishing Viral Replication Early in Infection.mBio. 2017 May 2;8(3):e01518-16. doi: 10.1128/mBio.01518-16.
82 Host-Epstein-Barr virus relationship affected by immunostimulation in HIV-infected patients representing distinct progressor profile groups.Scand J Infect Dis. 2012 May;44(5):388-92. doi: 10.3109/00365548.2011.645503. Epub 2012 Jan 15.
83 Endoplasmic reticulum aminopeptidase 2 haplotypes play a role in modulating susceptibility to HIV infection.AIDS. 2013 Jul 17;27(11):1697-706. doi: 10.1097/QAD.0b013e3283601cee.
84 Role of CD23 in astrocytes inflammatory reaction during HIV-1 related encephalitis. Cytokine. 2001 Jul 21;15(2):96-107. doi: 10.1006/cyto.2001.0896.
85 Possession of human leucocyte antigen DQ6 alleles and the rate of CD4 T-cell decline in human immunodeficiency virus-1 infection.Immunology. 2004 May;112(1):136-42. doi: 10.1111/j.1365-2567.2004.01848.x.
86 PNPLA3 Gene Polymorphisms in HCV/HIV-Coinfected Individuals.Dig Dis Sci. 2018 Nov;63(11):2969-2974. doi: 10.1007/s10620-018-5278-y. Epub 2018 Sep 14.
87 Human gene copy number variation and infectious disease.Hum Genet. 2014 Oct;133(10):1217-33. doi: 10.1007/s00439-014-1457-x. Epub 2014 Jun 5.
88 Activity of lysosomal exoglycosidases in saliva of patients with HIV infection.Adv Med Sci. 2007;52:186-90.
89 A systems approach identifies HIPK2 as a key regulator of kidney fibrosis.Nat Med. 2012 Mar 11;18(4):580-8. doi: 10.1038/nm.2685.
90 Different pattern of stool and plasma gastrointestinal damage biomarkers during primary and chronic HIV infection.PLoS One. 2019 Jun 11;14(6):e0218000. doi: 10.1371/journal.pone.0218000. eCollection 2019.
91 CD3(+)CD20(+) T cells and their roles in human diseases.Hum Immunol. 2019 Mar;80(3):191-194. doi: 10.1016/j.humimm.2019.01.001. Epub 2019 Jan 11.
92 IL-15 regulates susceptibility of CD4(+) T cells to HIV infection.Proc Natl Acad Sci U S A. 2018 Oct 9;115(41):E9659-E9667. doi: 10.1073/pnas.1806695115. Epub 2018 Sep 26.
93 CD4+ NK cells can be productively infected with HIV, leading to downregulation of CD4 expression and changes in function.Virology. 2009 Apr 25;387(1):59-66. doi: 10.1016/j.virol.2009.01.044. Epub 2009 Feb 28.
94 Association of interleukin-27 gene polymorphisms with susceptibility to HIV infection and disease progression.J Cell Mol Med. 2019 Apr;23(4):2410-2418. doi: 10.1111/jcmm.14067. Epub 2019 Jan 10.
95 CD4 recovery is associated with genetic variation in IFN and IL19 genes.Antiviral Res. 2019 Oct;170:104577. doi: 10.1016/j.antiviral.2019.104577. Epub 2019 Aug 3.
96 Short Communication: Nonprogressive HIV-1 Infection Is Associated with Expansion of IL-21R Expressing Class-Switched Memory B Cells.AIDS Res Hum Retroviruses. 2019 Aug;35(8):729-733. doi: 10.1089/AID.2019.0015. Epub 2019 Jun 11.
97 HIV Infection Functionally Impairs Mycobacterium tuberculosis-Specific CD4 and CD8 T-Cell Responses.J Virol. 2019 Feb 19;93(5):e01728-18. doi: 10.1128/JVI.01728-18. Print 2019 Mar 1.
98 Allele-specific long-distance regulation dictates IL-32 isoform switching and mediates susceptibility to HIV-1.Sci Adv. 2018 Feb 21;4(2):e1701729. doi: 10.1126/sciadv.1701729. eCollection 2018 Feb.
99 Evaluation of CD103 (E7) integrin expression by CD8 T cells in blood as a surrogate marker to predict cervical T cell responses in the female genital tract during HIV infection.Clin Immunol. 2011 Nov;141(2):143-51. doi: 10.1016/j.clim.2011.06.008. Epub 2011 Jul 2.
100 The pathogenesis of progressive multifocal leukoencephalopathy.Discov Med. 2011 Dec;12(67):495-503.
101 Selective targeting of ITK blocks multiple steps of HIV replication.Proc Natl Acad Sci U S A. 2008 May 6;105(18):6684-9. doi: 10.1073/pnas.0709659105. Epub 2008 Apr 28.
102 Serial deletion reveals structural basis and stability for the core enzyme activity of human glutaminase 1 isoforms: relevance to excitotoxic neurodegeneration.Transl Neurodegener. 2017 Apr 20;6:10. doi: 10.1186/s40035-017-0080-x. eCollection 2017.
103 KIR Gene Content Diversity in a Zimbabwean Population: Does KIR2DL2 Have a Role in Protection Against Human Immunodeficiency Virus Infection?.OMICS. 2016 Dec;20(12):727-735. doi: 10.1089/omi.2016.0154.
104 The differential impact of natural killer (NK) cell education via KIR2DL3 and KIR3DL1 on CCL4 secretion in the context of in-vitro HIV infection.Clin Exp Immunol. 2016 Dec;186(3):336-346. doi: 10.1111/cei.12849. Epub 2016 Sep 9.
105 Elevated HLA-A expression impairs HIV control through inhibition of NKG2A-expressing cells.Science. 2018 Jan 5;359(6371):86-90. doi: 10.1126/science.aam8825. Epub 2018 Jan 4.
106 Kynurenine 3-Monooxygenase Inhibition during Acute Simian Immunodeficiency Virus Infection Lowers PD-1 Expression and Improves Post-Combination Antiretroviral Therapy CD4(+) T Cell Counts and Body Weight.J Immunol. 2019 Aug 15;203(4):899-910. doi: 10.4049/jimmunol.1801649. Epub 2019 Jul 8.
107 Roles, function and relevance of LAG3 in HIV infection.PLoS Pathog. 2019 Jan 17;15(1):e1007429. doi: 10.1371/journal.ppat.1007429. eCollection 2019 Jan.
108 A pneumococcal capsular polysaccharide vaccine induces a repertoire shift with increased VH3 expression in peripheral B cells from human immunodeficiency virus (HIV)-uninfected but not HIV-infected persons.J Infect Dis. 2000 Apr;181(4):1313-21. doi: 10.1086/315405. Epub 2000 Apr 13.
109 Natural Killer (NK) Cell Education Differentially Influences HIV Antibody-Dependent NK Cell Activation and Antibody-Dependent Cellular Cytotoxicity.Front Immunol. 2017 Aug 24;8:1033. doi: 10.3389/fimmu.2017.01033. eCollection 2017.
110 Disruption of MAP kinase activation and nuclear factor binding to the IL-12 p40 promoter in HIV-infected myeloid cells.Clin Exp Immunol. 2004 Aug;137(2):329-40. doi: 10.1111/j.1365-2249.2004.02513.x.
111 HIV-1 transgenic rat CD4+ T cells develop decreased CD28 responsiveness and suboptimal Lck tyrosine dephosphorylation following activation.Virology. 2006 Sep 30;353(2):357-65. doi: 10.1016/j.virol.2006.05.026. Epub 2006 Jul 10.
112 Early SIV and HIV infection promotes the LILRB2/MHC-I inhibitory axis in cDCs.Cell Mol Life Sci. 2018 May;75(10):1871-1887. doi: 10.1007/s00018-017-2712-9. Epub 2017 Nov 13.
113 Discovery of Novel Small-Molecule Inhibitors of LIM Domain Kinase for Inhibiting HIV-1.J Virol. 2017 Jun 9;91(13):e02418-16. doi: 10.1128/JVI.02418-16. Print 2017 Jul 1.
114 Resistance profiles to antiretroviral drugs in HIV-1 drug-naive patients in Argentina.Antivir Ther. 2001 Mar;6(1):71-7.
115 Leukotriene A4 Hydrolase Genotype and HIV Infection Influence Intracerebral Inflammation and Survival From Tuberculous Meningitis.J Infect Dis. 2017 Apr 1;215(7):1020-1028. doi: 10.1093/infdis/jix050.
116 BLT-humanized C57BL/6 Rag2-/-c-/-CD47-/- mice are resistant to GVHD and develop B- and T-cell immunity to HIV infection.Blood. 2013 Dec 12;122(25):4013-20. doi: 10.1182/blood-2013-06-506949. Epub 2013 Sep 10.
117 Antifungal effects of lysozyme and lactoferrin against genetically similar, sequential Candida albicans isolates from a human immunodeficiency virus-infected southern Chinese cohort.J Clin Microbiol. 2001 Sep;39(9):3296-302. doi: 10.1128/JCM.39.9.3296-3302.2001.
118 Identification of novel therapeutic targets for HIV infection through functional genomic cDNA screening.Virology. 2007 May 25;362(1):16-25. doi: 10.1016/j.virol.2006.11.036. Epub 2007 Jan 25.
119 Global phosphoproteomics of CCR5-tropic HIV-1 signaling reveals reprogramming of cellular protein production pathways and identifies p70-S6K1 and MK2 as HIV-responsive kinases required for optimal infection of CD4+ T cells.Retrovirology. 2018 Jul 3;15(1):44. doi: 10.1186/s12977-018-0423-4.
120 Activation of TRPML1 clears intraneuronal A in preclinical models of HIV infection. J Neurosci. 2014 Aug 20;34(34):11485-503.
121 The full spectrum of Castleman disease: 273 patients studied over 20years.Br J Haematol. 2018 Jan;180(2):206-216. doi: 10.1111/bjh.15019. Epub 2017 Nov 16.
122 Effect of matrix metalloproteinase-21 (572C/T) polymorphism on HIV-associated neurocognitive disorder.APMIS. 2018 Apr;126(4):329-336. doi: 10.1111/apm.12817.
123 Midkine, a cytokine that inhibits HIV infection by binding to the cell surface expressed nucleolin.Cell Res. 2006 Feb;16(2):174-81. doi: 10.1038/sj.cr.7310024.
124 Role of NEDD8 in HIV-associated lipodystrophy.Differentiation. 2009 Feb;77(2):148-53. doi: 10.1016/j.diff.2008.09.016. Epub 2008 Nov 18.
125 NLRX1 Sequesters STING to Negatively Regulate the Interferon Response, Thereby Facilitating the Replication of HIV-1 and DNA Viruses.Cell Host Microbe. 2016 Apr 13;19(4):515-528. doi: 10.1016/j.chom.2016.03.001.
126 OGG1 Ser326Cys polymorphism, HIV, obesity and air pollution exposure influences adverse birth outcome susceptibility, within South African Women.Reprod Toxicol. 2018 Aug;79:8-15. doi: 10.1016/j.reprotox.2018.04.012. Epub 2018 Apr 27.
127 Polymorphisms of the kappa opioid receptor and prodynorphin genes: HIV risk and HIV natural history.J Acquir Immune Defic Syndr. 2013 May 1;63(1):17-26. doi: 10.1097/QAI.0b013e318285cd0c.
128 Association of polymorphisms of the mu opioid receptor gene with the severity of HIV infection and response to HIV treatment.J Infect Dis. 2012 Jun;205(11):1745-56. doi: 10.1093/infdis/jis264. Epub 2012 Mar 28.
129 Platelet reactivity in human immunodeficiency virus infected patients on dual antiplatelet therapy for an acute coronary syndrome: the EVERE2ST-HIV study.Eur Heart J. 2017 Jun 1;38(21):1676-1686. doi: 10.1093/eurheartj/ehw583.
130 Prolonged Antiretroviral Therapy in Adolescents With Vertical HIV Infection Leads to Different Cytokine Profiles Depending on Viremia Persistence.Pediatr Infect Dis J. 2019 Nov;38(11):1115-1120. doi: 10.1097/INF.0000000000002446.
131 Predicting cervical intraepithelial neoplasia recurrence in HIV-infected and -noninfected women by detecting aberrant promoter methylation in the CDH1, TIMP3, and MGMT genes.Arch Gynecol Obstet. 2018 Nov;298(5):971-979. doi: 10.1007/s00404-018-4899-x. Epub 2018 Sep 14.
132 Platelet-activating factor and its basic metabolic enzymes in blood of naive HIV-infected patients.Angiology. 2012 Jul;63(5):343-52. doi: 10.1177/0003319711420608. Epub 2011 Sep 22.
133 Impact of PNPLA3 variants on liver histology of 168 patients with HIV infection and chronic hepatitis C.Clin Microbiol Infect. 2016 Apr;22(4):372-378. doi: 10.1016/j.cmi.2015.11.025. Epub 2016 Jan 20.
134 Repair of oxidative DNA base damage in the host genome influences the HIV integration site sequence preference.PLoS One. 2014 Jul 22;9(7):e103164. doi: 10.1371/journal.pone.0103164. eCollection 2014.
135 Updates on HIV nonoccupational postexposure prophylaxis.Curr Opin Pediatr. 2019 Aug;31(4):454-461. doi: 10.1097/MOP.0000000000000775.
136 HIV in practice: current approaches and challenges in the diagnosis, treatment and management of HIV infection in Australia.HIV Med. 2018 Aug;19 Suppl 3:5-23. doi: 10.1111/hiv.12637.
137 PGL-1 and LID-1 antibody levels in HIV-infected and HIV-uninfected individuals in a Hansen's disease (leprosy) endemic area of Brazil.Immunobiology. 2020 Jan;225(1):151866. doi: 10.1016/j.imbio.2019.11.001. Epub 2019 Nov 10.
138 Frontline Science: c-Myc regulates P-selectin glycoprotein ligand-1 expression in monocytes during HIV-1 infection.J Leukoc Biol. 2017 Oct;102(4):953-964. doi: 10.1189/jlb.6HI0217-043R. Epub 2017 Jun 29.
139 Cocaine and sigma-1 receptors modulate HIV infection, chemokine receptors, and the HPA axis in the huPBL-SCID model. J Leukoc Biol. 2005 Dec;78(6):1198-203. doi: 10.1189/jlb.0405219. Epub 2005 Oct 4.
140 Increased proportion of KIR3DS1 homozygotes in HIV-exposed uninfected individuals.AIDS. 2008 Mar 12;22(5):595-9. doi: 10.1097/QAD.0b013e3282f56b23.
141 SLAMF7 Is a Critical Negative Regulator of IFN--Mediated CXCL10 Production in Chronic HIV Infection.J Immunol. 2019 Jan 1;202(1):228-238. doi: 10.4049/jimmunol.1800847. Epub 2018 Dec 10.
142 Regulated expression of sodium-dependent glutamate transporters and synthetase: a neuroprotective role for activated microglia and macrophages in HIV infection?.Brain Pathol. 2003 Apr;13(2):211-22. doi: 10.1111/j.1750-3639.2003.tb00020.x.
143 Enhanced susceptibility to human immunodeficiency virus infection in CD4+ T lymphocytes genetically deficient in CD43.AIDS Res Hum Retroviruses. 1995 Sep;11(9):1015-21. doi: 10.1089/aid.1995.11.1015.
144 Multiple strategies to identify HIV-positive black men who have sex with men and transgender women in New York City: a cross-sectional analysis of recruitment results.J Int AIDS Soc. 2018 Mar;21(3):e25091. doi: 10.1002/jia2.25091.
145 Alteration of inhibitory and activating natural killer cell receptor expression on T cells in human immunodeficiency virus-infected Chinese.Microbiol Immunol. 2011 Oct;55(10):715-25. doi: 10.1111/j.1348-0421.2011.00372.x.
146 Expression of the Inhibitory Receptor TIGIT Is Up-Regulated Specifically on NK Cells With CD226 Activating Receptor From HIV-Infected Individuals.Front Immunol. 2018 Oct 10;9:2341. doi: 10.3389/fimmu.2018.02341. eCollection 2018.
147 Decrease in thymidylate kinase activity in peripheral blood mononuclear cells from HIV-infected individuals.Biochem Pharmacol. 1998 Aug 1;56(3):389-95. doi: 10.1016/s0006-2952(98)00032-x.
148 Endosomal toll-like receptor gene polymorphisms and susceptibility to HIV and HCV co-infection - Differential influence in individuals with distinct ethnic background.Hum Immunol. 2017 Feb;78(2):221-226. doi: 10.1016/j.humimm.2017.01.001. Epub 2017 Jan 4.
149 A functional toll-like receptor 8 variant is associated with HIV disease restriction.J Infect Dis. 2008 Sep 1;198(5):701-9. doi: 10.1086/590431.
150 Glucocorticoid-induced tumor necrosis factor receptor family-related protein triggering enhances HIV-specific CD4+ T cell cytokine secretion and protects HIV-specific CD4+ T cells from apoptosis.J Infect Dis. 2007 Jul 1;196(1):43-9. doi: 10.1086/518613. Epub 2007 May 23.
151 Soluble TWEAK may predict carotid atherosclerosis in treated HIV infection.HIV Clin Trials. 2017 Jul;18(4):156-163. doi: 10.1080/15284336.2017.1366001. Epub 2017 Aug 22.
152 Gag-p6 Tsg101 binding site duplications in maternal-infant HIV infection.AIDS Res Hum Retroviruses. 2005 Mar;21(3):191-9. doi: 10.1089/aid.2005.21.191.
153 HIV-1 and HIV-2 infections induce autophagy in Jurkat and CD4+ T cells.Cell Signal. 2012 Jul;24(7):1414-9. doi: 10.1016/j.cellsig.2012.02.016. Epub 2012 Mar 2.
154 HCV adaptation to HIV coinfection.Infect Genet Evol. 2018 Nov;65:216-225. doi: 10.1016/j.meegid.2018.07.039. Epub 2018 Jul 31.
155 A SYSTEMATIC REVIEW ON THE INFLUENCE OF HLA-B POLYMORPHISMS ON HIV-1 MOTHER-TO-CHILD-TRANSMISSION.Braz J Infect Dis. 2019 Jan-Feb;23(1):53-59. doi: 10.1016/j.bjid.2018.12.002. Epub 2019 Feb 14.
156 Mortality in HIV infection is independently predicted by host iron status and SLC11A1 and HP genotypes, with new evidence of a gene-nutrient interaction.Am J Clin Nutr. 2009 Jul;90(1):225-33. doi: 10.3945/ajcn.2009.27709. Epub 2009 May 27.
157 Prevalence and correlates of MRSA and MSSA nasal carriage at a Ugandan regional referral hospital.J Antimicrob Chemother. 2017 Mar 1;72(3):888-892. doi: 10.1093/jac/dkw472.
158 Association of serum albumin and aspartate transaminase with 5-year all-cause mortality in HIV/hepatitis C virus coinfection and HIV monoinfection.AIDS. 2017 Jan 2;31(1):71-79. doi: 10.1097/QAD.0000000000001278.
159 Infant/child rapid serology tests fail to reliably assess HIV exposure among sick hospitalized infants.AIDS. 2017 Jul 17;31(11):F1-F7. doi: 10.1097/QAD.0000000000001562.
160 Serum paraoxonase-3 concentration in HIV-infected patients. Evidence for a protective role against oxidation.J Lipid Res. 2012 Jan;53(1):168-74. doi: 10.1194/jlr.P018457. Epub 2011 Oct 14.
161 Cerebrospinal Fluid Concentrations of the Synaptic Marker Neurogranin in Neuro-HIV and Other Neurological Disorders.Curr HIV/AIDS Rep. 2019 Feb;16(1):76-81. doi: 10.1007/s11904-019-00420-1.
162 Xpert MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.Cochrane Database Syst Rev. 2013 Jan 31;(1):CD009593. doi: 10.1002/14651858.CD009593.pub2.
163 Higher Body Mass Index Is Associated With Greater Proportions of Effector CD8+ T Cells Expressing CD57 in Women Living With HIV.J Acquir Immune Defic Syndr. 2017 Aug 15;75(5):e132-e141. doi: 10.1097/QAI.0000000000001376.
164 The VNTR polymorphism of the CLEC4M gene and susceptibility to HIV-1 infection in Han Chinese population.Infect Genet Evol. 2013 Jul;17:137-41. doi: 10.1016/j.meegid.2013.04.007. Epub 2013 Apr 17.
165 Genome-wide admixture and association study of subclinical atherosclerosis in the Women's Interagency HIV Study (WIHS).PLoS One. 2017 Dec 4;12(12):e0188725. doi: 10.1371/journal.pone.0188725. eCollection 2017.
166 Dock2 in the development of inflammation and cancer.Eur J Immunol. 2018 Jun;48(6):915-922. doi: 10.1002/eji.201747157. Epub 2018 Apr 11.
167 Coreceptor-Based Hematopoietic Stem Cell Gene Therapy for HIV Disease.Curr Stem Cell Res Ther. 2019;14(7):591-597. doi: 10.2174/1574888X14666190523094556.
168 NF45 and NF90 Bind HIV-1 RNA and Modulate HIV Gene Expression.Viruses. 2016 Feb 16;8(2):47. doi: 10.3390/v8020047.
169 Interaction of human immunodeficiency virus type 1 integrase with cellular nuclear import receptor importin 7 and its impact on viral replication.J Biol Chem. 2007 May 4;282(18):13456-67. doi: 10.1074/jbc.M610546200. Epub 2007 Mar 14.
170 Vaccine-induced V1V2-specific antibodies control and or protect against infection with HIV, SIV and SHIV.Curr Opin HIV AIDS. 2019 Jul;14(4):309-317. doi: 10.1097/COH.0000000000000551.
171 Galectin-9 Mediates HIV Transcription by Inducing TCR-Dependent ERK Signaling.Front Immunol. 2019 Feb 20;10:267. doi: 10.3389/fimmu.2019.00267. eCollection 2019.
172 The level of DING proteins is increased in HIV-infected patients: in vitro and in vivo studies.PLoS One. 2012;7(3):e33062. doi: 10.1371/journal.pone.0033062. Epub 2012 Mar 9.
173 Immune activation and IL-12 production during acute/early HIV infection in the absence and presence of highly active, antiretroviral therapy.J Leukoc Biol. 2008 Dec;84(6):1447-53. doi: 10.1189/jlb.0708438. Epub 2008 Sep 19.
174 The interferon-stimulated gene TRIM22: A double-edged sword in HIV-1 infection.Cytokine Growth Factor Rev. 2018 Apr;40:40-47. doi: 10.1016/j.cytogfr.2018.02.001. Epub 2018 Feb 10.
175 A Population Pharmacokinetic Analysis Shows that Arylacetamide Deacetylase (AADAC) Gene Polymorphism and HIV Infection Affect the Exposure of Rifapentine.Antimicrob Agents Chemother. 2019 Mar 27;63(4):e01964-18. doi: 10.1128/AAC.01964-18. Print 2019 Apr.
176 Physiological relevance of ACOT8-Nef interaction in HIV infection.Rev Med Virol. 2019 Sep;29(5):e2057. doi: 10.1002/rmv.2057. Epub 2019 Jun 9.
177 Cocaine modulates dendritic cell-specific C type intercellular adhesion molecule-3-grabbing nonintegrin expression by dendritic cells in HIV-1 patients.J Immunol. 2005 Jun 1;174(11):6617-26. doi: 10.4049/jimmunol.174.11.6617.
178 Preexposure Prophylaxis for the Prevention of HIV Infection: Evidence Report and Systematic Review for the US Preventive Services Task Force.JAMA. 2019 Jun 11;321(22):2214-2230. doi: 10.1001/jama.2019.2591.
179 Lack of permissivity of human monoclonal CD4+ lymphocytes to HIV.Cancer Detect Prev. 1990;14(4):445-56.
180 Stably expressed APOBEC3F has negligible antiviral activity.J Virol. 2010 Nov;84(21):11067-75. doi: 10.1128/JVI.01249-10. Epub 2010 Aug 11.
181 Evidence for BAG3 modulation of HIV-1 gene transcription.J Cell Physiol. 2007 Mar;210(3):676-83. doi: 10.1002/jcp.20865.
182 BATF Potentially Mediates Negative Regulation of PD-1/PD-Ls Pathway on T Cell Functions in Mycobacterium tuberculosis Infection.Front Immunol. 2019 Oct 15;10:2430. doi: 10.3389/fimmu.2019.02430. eCollection 2019.
183 HIV brain latency as measured by CSF BcL11b relates to disrupted brain cellular energy in virally suppressed HIV infection.AIDS. 2019 Mar 1;33(3):433-441. doi: 10.1097/QAD.0000000000002076.
184 Investigation of Cyclodextrin-Based Nanosponges for Solubility and Bioavailability Enhancement of Rilpivirine.AAPS PharmSciTech. 2018 Jul;19(5):2358-2369. doi: 10.1208/s12249-018-1064-6. Epub 2018 Jun 4.
185 What determines do-not-resuscitate status in critically ill HIV-infected patients admitted to ICU?.J Crit Care. 2019 Oct;53:207-211. doi: 10.1016/j.jcrc.2019.06.010. Epub 2019 Jun 19.
186 Purified recombinant CD4 inhibits HIV-1 infection of peripheral blood macrophages.Pathol Biol (Paris). 1991 Oct;39(8):754-8.
187 Tim-3 is a Marker of Plasmacytoid Dendritic Cell Dysfunction during HIV Infection and Is Associated with the Recruitment of IRF7 and p85 into Lysosomes and with the Submembrane Displacement of TLR9.J Immunol. 2017 Apr 15;198(8):3181-3194. doi: 10.4049/jimmunol.1601298. Epub 2017 Mar 6.
188 Selective miRNA Modulation Fails to Activate HIV Replication in InVitro Latency Models.Mol Ther Nucleic Acids. 2019 Sep 6;17:323-336. doi: 10.1016/j.omtn.2019.06.006. Epub 2019 Jun 20.
189 Update to CDC's U.S. Medical Eligibility Criteria for Contraceptive Use, 2016: Revised Recommendations for the Use of Hormonal Contraception Among Women at High Risk for HIV Infection.MMWR Morb Mortal Wkly Rep. 2017 Sep 22;66(37):990-994. doi: 10.15585/mmwr.mm6637a6.
190 NK Cells in HIV-1 Infection: From Basic Science to Vaccine Strategies.Front Immunol. 2018 Oct 17;9:2290. doi: 10.3389/fimmu.2018.02290. eCollection 2018.
191 Regulation of cyclin T1 during HIV replication and latency establishment in human memory CD4 T cells.Virol J. 2019 Feb 20;16(1):22. doi: 10.1186/s12985-019-1128-6.
192 IgG opsonization of HIV impedes provirus formation in and infection of dendritic cells and subsequent long-term transfer to T cells.J Immunol. 2007 Jun 15;178(12):7840-8. doi: 10.4049/jimmunol.178.12.7840.
193 A high mucosal blocking score is associated with HIV protection.AIDS. 2019 Mar 1;33(3):411-423. doi: 10.1097/QAD.0000000000002099.
194 Negative Checkpoint Regulatory Molecule 2B4 (CD244) Upregulation Is Associated with Invariant Natural Killer T Cell Alterations and Human Immunodeficiency Virus Disease Progression.Front Immunol. 2017 Mar 27;8:338. doi: 10.3389/fimmu.2017.00338. eCollection 2017.
195 Long-term in vivo survival of receptor-modified syngeneic T cells in patients with human immunodeficiency virus infection.Blood. 2000 Jul 15;96(2):467-74.
196 CBF and HIV Infection.Adv Exp Med Biol. 2017;962:415-431. doi: 10.1007/978-981-10-3233-2_25.
197 Anti-HERV-K (HML-2) capsid antibody responses in HIV elite controllers.Retrovirology. 2017 Aug 22;14(1):41. doi: 10.1186/s12977-017-0365-2.
198 Impact of Aging and HIV Infection on the Function of the C-Type Lectin Receptor MINCLE in Monocytes.J Gerontol A Biol Sci Med Sci. 2019 May 16;74(6):794-801. doi: 10.1093/gerona/gly209.
199 Minimal change nephrotic syndrome in patients infected with human immunodeficiency virus: a retrospective study of 8 cases.BMC Nephrol. 2018 Nov 20;19(1):331. doi: 10.1186/s12882-018-1132-x.
200 The lectin pathway of complement: advantage or disadvantage in HIV pathogenesis?.Clin Immunol. 2014 Sep;154(1):13-25. doi: 10.1016/j.clim.2014.06.002. Epub 2014 Jun 11.
201 Soluble Factors Secreted by Endothelial Cells Allow for Productive and Latent HIV-1 Infection in Resting CD4(+) T Cells.AIDS Res Hum Retroviruses. 2017 Feb;33(2):110-120. doi: 10.1089/AID.2016.0058. Epub 2016 Oct 5.
202 Role and evolution of viral tropism in patients with advanced HIV disease receiving intensified initial regimen in the ANRS 130 APOLLO trial.J Antimicrob Chemother. 2013 Mar;68(3):690-6. doi: 10.1093/jac/dks455. Epub 2012 Nov 14.
203 Key Determinants of Human -Defensin 5 and 6 for Enhancement of HIV Infectivity.Viruses. 2017 Aug 29;9(9):244. doi: 10.3390/v9090244.
204 Reconnaissance of the candidate genes involved in the pathogenesis of human immunodeficiency virus and targeted by antiretroviral therapy.J Med Virol. 2019 Dec;91(12):2134-2141. doi: 10.1002/jmv.25549. Epub 2019 Jul 30.
205 DRAM triggers lysosomal membrane permeabilization and cell death in CD4(+) T cells infected with HIV.PLoS Pathog. 2013;9(5):e1003328. doi: 10.1371/journal.ppat.1003328. Epub 2013 May 2.
206 Molecular signatures of T-cell inhibition in HIV-1 infection.Retrovirology. 2013 Mar 20;10:31. doi: 10.1186/1742-4690-10-31.
207 Reduced eIF3d accelerates HIV disease progression by attenuating CD8+ T cell function.J Transl Med. 2019 May 22;17(1):167. doi: 10.1186/s12967-019-1925-0.
208 Elevated aspartic proteinase secretion and experimental pathogenicity of Candida albicans isolates from oral cavities of subjects infected with human immunodeficiency virus.Infect Immun. 1996 Feb;64(2):466-71. doi: 10.1128/iai.64.2.466-471.1996.
209 Human Immunodeficiency Virus C.1086 Envelope gp140 Protein Boosts following DNA/Modified Vaccinia Virus Ankara Vaccination Fail To Enhance Heterologous Anti-V1V2 Antibody Response and Protection against Clade C Simian-Human Immunodeficiency Virus Challenge.J Virol. 2019 Sep 30;93(20):e00934-19. doi: 10.1128/JVI.00934-19. Print 2019 Oct 15.
210 HIV-1 gp120 envelope glycoprotein determinants for cytokine burst in human monocytes.PLoS One. 2017 Mar 27;12(3):e0174550. doi: 10.1371/journal.pone.0174550. eCollection 2017.
211 Associations of Liver Disease with Alcohol Use among People Living with HIV and the Role of Hepatitis C: The New Orleans Alcohol Use in HIV Study.Alcohol Alcohol. 2020 Feb 7;55(1):28-36. doi: 10.1093/alcalc/agz089.
212 Flt3L-Mediated Expansion of Plasmacytoid Dendritic Cells Suppresses HIV Infection in Humanized Mice.Cell Rep. 2019 Nov 26;29(9):2770-2782.e5. doi: 10.1016/j.celrep.2019.10.094.
213 A genetic polymorphism of FREM1 is associated with resistance against HIV infection in the Pumwani sex worker cohort.J Virol. 2012 Nov;86(21):11899-905. doi: 10.1128/JVI.01499-12. Epub 2012 Aug 22.
214 Secretor polymorphism and human immunodeficiency virus infection in Senegalese women.J Infect Dis. 2000 Feb;181(2):737-9. doi: 10.1086/315234.
215 Cofilin hyperactivation in HIV infection and targeting the cofilin pathway using an anti-(4)(7) integrin antibody.Sci Adv. 2019 Jan 9;5(1):eaat7911. doi: 10.1126/sciadv.aat7911. eCollection 2019 Jan.
216 Macrogolgin--a new 376 kD Golgi complex outer membrane protein as target of antibodies in patients with rheumatic diseases and HIV infections.J Autoimmun. 1994 Feb;7(1):67-91. doi: 10.1006/jaut.1994.1006.
217 An Integrated Pan-Cancer Analysis and Structure-Based Virtual Screening of GPR15.Int J Mol Sci. 2019 Dec 10;20(24):6226. doi: 10.3390/ijms20246226.
218 Expression of PD-1 and Tim-3 markers of T-cell exhaustion is associated with CD4 dynamics during the course of untreated and treated HIV infection.PLoS One. 2018 Mar 8;13(3):e0193829. doi: 10.1371/journal.pone.0193829. eCollection 2018.
219 Rapid HCP5 single-nucleotide polymorphism genotyping: a simple allele-specific PCR method for prediction of hypersensitivity reaction to Abacavir.Clin Chim Acta. 2011 Jul 15;412(15-16):1382-4. doi: 10.1016/j.cca.2011.04.010. Epub 2011 Apr 14.
220 HLA-F*01:01 presents peptides with N-terminal flexibility and a preferred length of 16 residues.Immunogenetics. 2019 May;71(5-6):353-360. doi: 10.1007/s00251-019-01112-1. Epub 2019 Apr 2.
221 HspBP1 and anti-HspBP1 levels in the serum of HIV-infected individuals are associated to the disease progression.J Appl Microbiol. 2019 Aug;127(2):576-585. doi: 10.1111/jam.14230. Epub 2019 Jun 7.
222 The role of trophoblast cell receptor expression in HIV-1 passage across the placenta in pre-eclampsia: an observational study.BJOG. 2017 May;124(6):920-928. doi: 10.1111/1471-0528.14311. Epub 2016 Oct 3.
223 The polymorphisms in DC-SIGNR affect susceptibility to HIV type 1 infection.AIDS Res Hum Retroviruses. 2007 May;23(5):686-92. doi: 10.1089/aid.2006.0212.
224 IFI16 DNA sensor is required for death of lymphoid CD4 T cells abortively infected with HIV.Science. 2014 Jan 24;343(6169):428-32. doi: 10.1126/science.1243640. Epub 2013 Dec 19.
225 Kinetics of Early Innate Immune Activation during HIV-1 Infection of Humanized Mice.J Virol. 2019 May 15;93(11):e02123-18. doi: 10.1128/JVI.02123-18. Print 2019 Jun 1.
226 Rhesus macaque IFITM3 gene polymorphisms and SIV infection.PLoS One. 2017 Mar 3;12(3):e0172847. doi: 10.1371/journal.pone.0172847. eCollection 2017.
227 Expression Pattern of Individual IFNA Subtypes in Chronic HIV Infection.J Interferon Cytokine Res. 2017 Dec;37(12):541-549. doi: 10.1089/jir.2017.0076.
228 HIV induces production of IL-18 from intestinal epithelial cells that increases intestinal permeability and microbial translocation.PLoS One. 2018 Mar 30;13(3):e0194185. doi: 10.1371/journal.pone.0194185. eCollection 2018.
229 Disruption of the gamma c cytokine network in T cells during HIV infection.Cytokine. 2008 Jul;43(1):1-14. doi: 10.1016/j.cyto.2008.03.001. Epub 2008 Apr 15.
230 Racial differences in prostate cancer risk in young HIV-positive and HIV-negative men: a prospective cohort study.Cancer Causes Control. 2017 Jul;28(7):767-777. doi: 10.1007/s10552-017-0896-9. Epub 2017 Apr 27.
231 Erythrocyte Inosine triphosphatase activity: A potential biomarker for adverse events during combination antiretroviral therapy for HIV.PLoS One. 2018 Jan 12;13(1):e0191069. doi: 10.1371/journal.pone.0191069. eCollection 2018.
232 Using safe, affordable and accessible non-steroidal anti-inflammatory drugs to reduce the number of HIV target cells in the blood and at the female genital tract.J Int AIDS Soc. 2018 Jul;21(7):e25150. doi: 10.1002/jia2.25150.
233 Cytomegalovirus-Driven Adaption of Natural Killer Cells in NKG2C(null) Human Immunodeficiency Virus-Infected Individuals.Viruses. 2019 Mar 9;11(3):239. doi: 10.3390/v11030239.
234 Natural killer (NK) cell receptor-HLA ligand genotype combinations associated with protection from HIV infection: investigation of how protective genotypes influence anti HIV NK cell functions.AIDS Res Ther. 2017 Sep 12;14(1):38. doi: 10.1186/s12981-017-0172-9.
235 NK cytotoxicity against CD4+ T cells during HIV-1 infection: a gp41 peptide induces the expression of an NKp44 ligand.Proc Natl Acad Sci U S A. 2005 Aug 2;102(31):10981-6. doi: 10.1073/pnas.0504315102. Epub 2005 Jul 26.
236 Immune activation in HIV/HCV-infected patients is associated with low-level expression of liver expressed antimicrobial peptide-2 (LEAP-2).J Clin Pathol. 2013 Nov;66(11):967-75. doi: 10.1136/jclinpath-2013-201581. Epub 2013 Aug 12.
237 LILRA3 deletion is a genetic risk factor of HIV infection.AIDS. 2017 Jan 2;31(1):25-34. doi: 10.1097/QAD.0000000000001304.
238 Posttranscriptional Regulation of HIV-1 Gene Expression during Replication and Reactivation from Latency by Nuclear Matrix Protein MATR3.mBio. 2018 Nov 13;9(6):e02158-18. doi: 10.1128/mBio.02158-18.
239 Congenital Tracheobronchomegaly (Mounier-Kuhn Syndrome) in a Woman with Human Immunodeficiency Virus: A Case Report.Cureus. 2017 Apr 4;9(4):e1136. doi: 10.7759/cureus.1136.
240 Quantitative analysis of differentially expressed saliva proteins in human immunodeficiency virus type 1 (HIV-1) infected individuals.Anal Chim Acta. 2013 Apr 24;774:61-6. doi: 10.1016/j.aca.2013.02.038. Epub 2013 Mar 1.
241 Genetic associations of variants in genes encoding HIV-dependency factors required for HIV-1 infection.J Infect Dis. 2010 Dec 15;202(12):1836-45. doi: 10.1086/657322.
242 A novel ligand on astrocytes interacts with natural cytotoxicity receptor NKp44 regulating immune response mediated by NK cells.PLoS One. 2018 Feb 15;13(2):e0193008. doi: 10.1371/journal.pone.0193008. eCollection 2018.
243 Impaired plasmacytoid dendritic cell (PDC)-NK cell activity in viremic human immunodeficiency virus infection attributable to impairments in both PDC and NK cell function.J Virol. 2009 Nov;83(21):11175-87. doi: 10.1128/JVI.00753-09. Epub 2009 Aug 19.
244 Profile of neuronal exosomes in HIV cognitive impairment exposes sex differences.AIDS. 2019 Sep 1;33(11):1683-1692. doi: 10.1097/QAD.0000000000002272.
245 Mitochondrial complex I activity is impaired during HIV-1-induced T-cell apoptosis.Cell Death Differ. 2005 Nov;12(11):1417-28. doi: 10.1038/sj.cdd.4401668.
246 Genome-Wide Association and Replication Study of Hepatotoxicity Induced by Antiretrovirals Alone or with Concomitant Anti-Tuberculosis Drugs.OMICS. 2017 Apr;21(4):207-216. doi: 10.1089/omi.2017.0019.
247 The base excision repair pathway is required for efficient lentivirus integration.PLoS One. 2011 Mar 23;6(3):e17862. doi: 10.1371/journal.pone.0017862.
248 Haptoglobin polymorphism in a HIV-1 seropositive Brazilian population.J Clin Pathol. 2006 May;59(5):550-3. doi: 10.1136/jcp.2005.027375.
249 Pannexin1 Channels Are Required for Chemokine-Mediated Migration of CD4+ T Lymphocytes: Role in Inflammation and Experimental Autoimmune Encephalomyelitis.J Immunol. 2016 May 15;196(10):4338-47. doi: 10.4049/jimmunol.1502440. Epub 2016 Apr 13.
250 Pregnancy-associated plasma protein-a is associated with subclinical atherosclerosis in men with HIV infection.J Investig Med. 2019 Jun;67(5):821-825. doi: 10.1136/jim-2018-000859. Epub 2018 Nov 28.
251 High frequency of a 30-bp deletion of Epstein-Barr virus latent membrane protein 1 gene in primary HIV non-Hodgkin's brain lymphomas.Neuropathol Appl Neurobiol. 2002 Dec;28(6):471-9. doi: 10.1046/j.1365-2990.2002.t01-1-00418.x.
252 New approaches to making the microenvironment of the female reproductive tract hostile to HIV.Am J Reprod Immunol. 2011 Mar;65(3):334-43. doi: 10.1111/j.1600-0897.2010.00949.x. Epub 2011 Jan 12.
253 HIV infection, high-risk behaviors and substance use in homeless men sheltered in therapeutic communities in Central Brazil.Int J STD AIDS. 2018 Nov;29(11):1084-1088. doi: 10.1177/0956462418767188. Epub 2018 Jun 3.
254 Dissociated production of perforin, granzyme B, and IFN-gamma by HIV-specific CD8(+) cells in HIV infection.AIDS Res Hum Retroviruses. 2008 Jan;24(1):62-71. doi: 10.1089/aid.2007.0125.
255 A coupled fluorescence-based assay for the detection of protein arginine N-methyltransferase 6 (PRMT6) enzymatic activity.Anal Biochem. 2018 Apr 15;547:7-13. doi: 10.1016/j.ab.2018.01.023. Epub 2018 Feb 2.
256 CD4 cell count variability with repeat testing in South Africa: Should reporting include both absolute counts and ranges of plausible values?.Int J STD AIDS. 2018 Nov;29(11):1048-1056. doi: 10.1177/0956462418771768. Epub 2018 May 11.
257 Haplotype analysis of HLA-A, -B antigens and -DRB1 alleles in south Indian HIV-1-infected patients with and without pulmonary tuberculosis.Int J Immunogenet. 2009 Jun;36(3):129-33. doi: 10.1111/j.1744-313X.2009.00835.x.
258 The electrophysiology of neuroHIV: A systematic review of EEG and MEG studies in people with HIV infection since the advent of highly-active antiretroviral therapy.Clin Neurophysiol. 2017 Jun;128(6):965-976. doi: 10.1016/j.clinph.2017.03.035. Epub 2017 Mar 31.
259 Quantitation of parvalbumin+ neurons and human immunodeficiency virus type 1 (HIV-1) regulatory gene expression in the HIV-1 transgenic rat: effects of vitamin A deficiency and morphine.J Neurovirol. 2010 Feb;16(1):33-40. doi: 10.3109/13550280903555712.
260 Regulation of CD4 expression via recycling by HRES-1/RAB4 controls susceptibility to HIV infection.J Biol Chem. 2006 Nov 10;281(45):34574-91. doi: 10.1074/jbc.M606301200. Epub 2006 Aug 24.
261 Endothelial Glycocalyx Damage and Renal Dysfunction in HIV Patients Receiving Combined Antiretroviral Therapy.AIDS Res Hum Retroviruses. 2017 Jul;33(7):703-710. doi: 10.1089/AID.2016.0284. Epub 2017 Apr 18.
262 RbAp48, a novel inhibitory factor that regulates the transcription of human immunodeficiency virus type 1.Int J Mol Med. 2016 Jul;38(1):267-74. doi: 10.3892/ijmm.2016.2598. Epub 2016 May 19.
263 RNAi in combination with a ribozyme and TAR decoy for treatment of HIV infection in hematopoietic cell gene therapy.Ann N Y Acad Sci. 2006 Oct;1082:172-9. doi: 10.1196/annals.1348.006.
264 Epigenetic regulation of RCAN1 expression in kidney disease and its role in podocyte injury.Kidney Int. 2018 Dec;94(6):1160-1176. doi: 10.1016/j.kint.2018.07.023. Epub 2018 Oct 23.
265 The HLA-B/-C haplotype block contains major determinants for host control of HIV.Genes Immun. 2009 Dec;10(8):673-7. doi: 10.1038/gene.2009.58. Epub 2009 Aug 20.
266 Lability of antiretroviral drug resistance mutations--correlates with immunological and virological responses.Curr HIV Res. 2007 Jul;5(4):430-9. doi: 10.2174/157016207781024009.
267 Cutting edge: Prolonged exposure to HIV reinforces a poised epigenetic program for PD-1 expression in virus-specific CD8 T cells.J Immunol. 2013 Jul 15;191(2):540-4. doi: 10.4049/jimmunol.1203161. Epub 2013 Jun 14.
268 Deep sequencing of RYR3 gene identifies rare and common variants associated with increased carotid intima-media thickness (cIMT) in HIV-infected individuals.J Hum Genet. 2015 Feb;60(2):63-7. doi: 10.1038/jhg.2014.104. Epub 2014 Dec 11.
269 BCL6 Inhibitor-Mediated Downregulation of Phosphorylated SAMHD1 and T Cell Activation Are Associated with Decreased HIV Infection and Reactivation.J Virol. 2019 Jan 4;93(2):e01073-18. doi: 10.1128/JVI.01073-18. Print 2019 Jan 15.
270 The PNPLA3 Genetic Variant rs738409 Influences the Progression to Cirrhosis in HIV/Hepatitis C Virus Coinfected Patients.PLoS One. 2016 Dec 14;11(12):e0168265. doi: 10.1371/journal.pone.0168265. eCollection 2016.
271 Structural characterization of semen coagulum-derived SEM1(86-107) amyloid fibrils that enhance HIV-1 infection.Biochemistry. 2014 May 27;53(20):3267-77. doi: 10.1021/bi500427r. Epub 2014 May 12.
272 Semaphorin4A causes loss of mature oligodendrocytes and demyelination in vivo.J Neuroinflammation. 2019 Feb 8;16(1):28. doi: 10.1186/s12974-019-1420-9.
273 Dendritic cell immunotherapy followed by cART interruption during HIV-1 infection induces plasma protein markers of cellular immunity and neutrophil recruitment.PLoS One. 2018 Feb 1;13(2):e0192278. doi: 10.1371/journal.pone.0192278. eCollection 2018.
274 The anti-inflammatory IL-37/SIGIRR axis is functionally compromised in HIV infection.AIDS. 2019 Sep 1;33(11):1693-1703. doi: 10.1097/QAD.0000000000002271.
275 Altered signaling lymphocytic activation molecule (SLAM) expression in HIV infection and redirection of HIV-specific responses via SLAM triggering.Clin Immunol. 1999 Sep;92(3):276-84. doi: 10.1006/clim.1999.4747.
276 Dephosphorylation activates the interferon-stimulated Schlafen family member 11 in the DNA damage response.J Biol Chem. 2019 Oct 4;294(40):14674-14685. doi: 10.1074/jbc.RA118.006588. Epub 2019 Aug 8.
277 Urine assay for tenofovir to monitor adherence in real time to tenofovir disoproxil fumarate/emtricitabine as pre-exposure prophylaxis.HIV Med. 2017 Jul;18(6):412-418. doi: 10.1111/hiv.12518. Epub 2017 Apr 26.
278 STING dependent sensing - Does HIV actually care?.Cytokine Growth Factor Rev. 2018 Apr;40:68-76. doi: 10.1016/j.cytogfr.2018.03.002. Epub 2018 Mar 9.
279 SUN2 Silencing Impairs CD4 T Cell Proliferation and Alters Sensitivity to HIV-1 Infection Independently of Cyclophilin A.J Virol. 2017 Feb 28;91(6):e02303-16. doi: 10.1128/JVI.02303-16. Print 2017 Mar 15.
280 Darunavir for the treatment of HIV infection.Expert Opin Pharmacother. 2018 Jul;19(10):1149-1163. doi: 10.1080/14656566.2018.1484901. Epub 2018 Jun 18.
281 HIV Tat protein inhibits hERG K+ channels: a potential mechanism of HIV infection induced LQTs.J Mol Cell Cardiol. 2011 Nov;51(5):876-80. doi: 10.1016/j.yjmcc.2011.07.017. Epub 2011 Jul 28.
282 Spatial genetic structure of two HIV-I-resistant polymorphisms (CCR2-64 I and SDF1-3'A) alleles in population of Shandong Province, China.Biomed Environ Sci. 2005 Aug;18(4):241-53.
283 Human IL-18 receptor and ST2L are stable and selective markers for the respective type 1 and type 2 circulating lymphocytes.J Immunol. 2001 Aug 1;167(3):1238-44. doi: 10.4049/jimmunol.167.3.1238.
284 Enhancement of HIV-specific CD8 T cell responses by dual costimulation with CD80 and CD137L.J Immunol. 2005 Nov 15;175(10):6378-89. doi: 10.4049/jimmunol.175.10.6378.
285 A trojan horse for human immunodeficiency virus.Chem Biol. 2015 Mar 19;22(3):313-4. doi: 10.1016/j.chembiol.2015.03.002.
286 Effect of IL-7 Therapy on Phospho-Ribosomal Protein S6 and TRAF1 Expression in HIV-Specific CD8 T Cells in Patients Receiving Antiretroviral Therapy.J Immunol. 2018 Jan 15;200(2):558-564. doi: 10.4049/jimmunol.1601254. Epub 2017 Dec 8.
287 Polymorphisms in TREX1 and susceptibility to HIV-1 infection.Int J Immunogenet. 2013 Dec;40(6):492-4. doi: 10.1111/iji.12071. Epub 2013 Jun 15.
288 Genetic determinants of HIV-1 infection and progression to AIDS: susceptibility to HIV infection.Tissue Antigens. 2009 Apr;73(4):289-301. doi: 10.1111/j.1399-0039.2009.01220.x.
289 DNA Methylation Markers of Type 2 Diabetes Mellitus Among Male Veterans With or Without Human Immunodeficiency Virus Infection.J Infect Dis. 2019 May 24;219(12):1959-1962. doi: 10.1093/infdis/jiz023.